⌘K

Home/Filings/4/0001104659-21-025196

4//SEC Filing

Cavan John T 4

Accession 0001104659-21-025196

CIK 0001583771other

View on SEC.gov Company Profile

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 4:05 PM ET

Size

4.6 KB

Accession

0001104659-21-025196

Insider Transaction Report

Form 4

Period: 2021-02-18

Hepion Pharmaceuticals, Inc.HEPA

Chief Financial Officer

Transactions

Purchase
Common Stock
2021-02-18$2.00/sh+10,000$20,000→ 14,800 total

Documents

1 file

4
tm217063-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Hepion Pharmaceuticals, Inc.

CIK 0001583771

Entity typeother

Related Parties

1

filerCIK 0001503738

Filing Metadata

Form type: 4
Filed: Feb 17, 7:00 PM ET
Accepted: Feb 18, 4:05 PM ET
Size: 4.6 KB

View on SEC.gov